|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV034599517 |
003 |
DE-627 |
005 |
20230624014253.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2015 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2015.07.008
|2 doi
|
028 |
5 |
2 |
|a GBVA2015012000027.pica
|
035 |
|
|
|a (DE-627)ELV034599517
|
035 |
|
|
|a (ELSEVIER)S0378-3782(15)00155-3
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Massaro, An N.
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Neonatal neurobehavior after therapeutic hypothermia for hypoxic ischemic encephalopathy
|
264 |
|
1 |
|c 2015
|
300 |
|
|
|a 7
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a Perinatal hypoxic ischemic encephalopathy (HIE) is a major cause of neurodevelopmental impairment including cerebral palsy and intellectual disability. Brain magnetic resonance imaging is the gold standard for acute assessment of cerebral injury in HIE. Limited data are available regarding the significance of clinically manifested neurobehavioral impairments in the neonatal period.
|
700 |
1 |
|
|a Evangelou, Iordanis
|4 oth
|
700 |
1 |
|
|a Brown, Judy
|4 oth
|
700 |
1 |
|
|a Fatemi, Ali
|4 oth
|
700 |
1 |
|
|a Vezina, Gilbert
|4 oth
|
700 |
1 |
|
|a McCarter, Robert
|4 oth
|
700 |
1 |
|
|a Glass, Penny
|4 oth
|
700 |
1 |
|
|a Limperopoulos, Catherine
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:91
|g year:2015
|g number:10
|g pages:593-599
|g extent:7
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2015.07.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 91
|j 2015
|e 10
|h 593-599
|g 7
|
953 |
|
|
|2 045F
|a 610
|